Literature DB >> 15529254

Use of the P gene to genotype human metapneumovirus identifies 4 viral subtypes.

Ian M Mackay1, Seweryn Bialasiewicz, Zubair Waliuzzaman, Glenys R Chidlow, David C Fegredo, Somprasong Laingam, Penny Adamson, Gerald B Harnett, William Rawlinson, Michael D Nissen, Theo P Sloots.   

Abstract

This study, conducted during 2001-2003, undertook the screening of patients with acute infectious respiratory-tract disease. A random selection of positive specimens was used for sequencing studies of the human metapneumovirus (hMPV) nucleoprotein gene and the phosphoprotein (P) gene. Australian and international sequences were compared, and a global classification scheme was developed. The hMPV P gene was an ideal molecular target for the detection and genotyping of hMPV. The region contained conserved sequences for reverse-transcriptase-polymerase chain-reaction primers and adequate variability to permit the accurate genotyping of the virus into 2 main lineages and 4 sublineages. Establishing viral identity is essential for the linking of genotype and disease severity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529254     DOI: 10.1086/425013

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.

Authors:  Karen A Herd; Suresh Mahalingam; Ian M Mackay; Michael Nissen; Theo P Sloots; Robert W Tindle
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies.

Authors:  Elena Percivalle; Antonella Sarasini; Livia Visai; M Grazia Revello; Giuseppe Gerna
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Noninvasive monitoring of respiratory viruses in wild chimpanzees.

Authors:  Sophie Köndgen; Svenja Schenk; Georg Pauli; Christophe Boesch; Fabian H Leendertz
Journal:  Ecohealth       Date:  2010-09-24       Impact factor: 3.184

4.  Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center.

Authors:  Gregory C Gray; Ana W Capuano; Sharon F Setterquist; Dean D Erdman; Newell D Nobbs; Yacine Abed; Gary V Doern; Sarah E Starks; Guy Boivin
Journal:  J Clin Virol       Date:  2006-09-27       Impact factor: 3.168

5.  The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.

Authors:  John V Williams; Sharon J Tollefson; Joyce E Johnson; James E Crowe
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 6.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.

Authors:  Céline Deffrasnes; Marie-Eve Hamelin; Gregory A Prince; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

8.  High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany.

Authors:  Jessica Lüsebrink; Christoph Wiese; Anne Thiel; Ramona-Liza Tillmann; Vanessa Ditt; Andreas Müller; Oliver Schildgen; Verena Schildgen
Journal:  Clin Vaccine Immunol       Date:  2009-12-30

9.  A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Authors:  John V Williams; Zhifeng Chen; Gabriella Cseke; David W Wright; Christopher J Keefer; Sharon J Tollefson; Ann Hessell; Amy Podsiad; Bryan E Shepherd; Pietro Paolo Sanna; Dennis R Burton; James E Crowe; R Anthony Williamson
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  Human metapneumovirus in children, Singapore.

Authors:  Liat Hui Loo; Boon Huan Tan; Ley Moy Ng; Nancy W S Tee; Raymond T P Lin; Richard J Sugrue
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.